medigraphic.com
ISSN 0188-9796 (Print)

2012, Number 3

<< Back Next >>

Rev Endocrinol Nutr 2012; 20 (3)

Prevalence of depresión and associated risk factors in patients with type 2 diabestes mellitus at National Medical Center 20 de noviembre

León AEJ, Guillén GMÁ, Vergara LA

Language: Spanish
References: 23
Page: 102-106
PDF size: 164.52 Kb.


ABSTRACT

Objective: To identify the prevalence and risk factors associated with depression in patients with diabetes in the Endocrinology Service of Centro Médico Nacional «20 de Noviembre». Material and methods: A cross-sectional study was carried out among a population of 168 patients with diabetes in whom Becks depression scale was applied by direct interview. Clinical and biochemical data regarding duration of diabetes and degree of metabolic control, as well as the presence of diabetic complication, was analyzed, trying to find correlation with the presence and severity of depression. Statistical analysis was carried out using SPSS software. Results: Depression was diagnosed in 62 (36.9%) patients, 35 (20.85%) have mild depression, 22 (13.1%) moderate depression and 5 (3%) had severe depression. Age, gender, marital status and BMI were not associated with the presence of depression. There is an association between depression and higher education level (p = 0.038), as well as a longer history of diabetes (p = 0.017) and insulin use (p = 0.037). No statistically significant association was obtained when we correlate depression with the glycated hemoglobin out of target, diabetic retinopathy and diabetic nephropathy (KDOQI degrees VI y V). Conclusions: The prevalence of depression was 36.9%. Is positively related to time of evolution of diabetes, insulin use and higher educational level.


REFERENCES

  1. Finkelstein EA, Bray JW, Chen H, Larson MJ, Miller K, Tompkins C, Keme A, Manderscheid R. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care. 2003; 26: 415-420.

  2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24: 1069-1078.

  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-1053.

  4. Bello M, Puentes-Rosas E, Medina-Mora ME, Lozano R. Prevalencia y diagnóstico de depresión en población adulta en México. Salud Publica Mex. 2005; 47: 4-11.

  5. Norris SL. Health-related quality of life among adults with diabetes. Curr Diab Rep. 2005; 5: 124-130.

  6. Bisschop MI, Kriegsman MW, Beekman ATF, Deeg DJH. Chronic diseases and depression: the modifying role of psychosocial resources. Soc Sci Med. 2004; 59: 721–733.

  7. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997; 59: 24–31.

  8. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T. How to screen for depression and emotional problems in patients with diabetes. Diabetologia. 2006; 49: 469–477.

  9. Vázquez FL, Torres-Iglesias A. Análisis sobre la investigación de la prevención de episodios nuevos de depresión. Clínica y Salud. 2007; 18: 221-246.

  10. Donohue JM, Pincus HA. Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment. Pharmacoeconomics. 2007; 25: 7-24.

  11. Sobocki P, Jönsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006; 9: 87-98.

  12. Cepoiu M, McCusker J, Cole MG, Sewitch M, Belzile E, Ciampi A. Recognition of depression by non-psychiatric physicians--a systematic literature review and meta-analysis. J Gen Intern Med. 2008; 23: 25-36.

  13. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes. Impact of depressive symptoms on adherence, function and costs. Arch Intern Med. 2000; 160: 3278–3285.

  14. Revised global burden of disease (GBD) 2002 estimates. Ginebra, OMS, 2005 (http://www.who.int/healthinfo/bogbd2002revised/en/index.html)

  15. Jackson, SW. Historia de la melancolía y la depresión. Rev Internat Psychiatry. 1961; 6: 1-8.

  16. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, Girolamo G, De Graaf R, Gureje O, Haro JM, Daram EG, Kessler RC, Kovess V, Lane MC, Lee S, Levinson D, Ona Y, Petukhova M, Posada-Villa J, Seedat S, Wells JE. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the word. WHO. Word mental health surveys. Lancet. 2007; 370: 841-850.

  17. Remick RA. Diagnosis and management of depression in primary care: A clinical update and review. CMAJ. 2002; 167: 1253-1260.

  18. Lustman PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes. 2000; 23: 934-942.

  19. Pouwder F, Beekman ATF, Nijpels G, Dekker JM, Snoek FJ, Kostense PJ, Heine RJ, Deeg DJH. Rates and risks for co-morbid depression in patients with type 2 diabetes mellitus. Diabetologia. 2003; 46: 892-898.

  20. Larijani B, Shahi BMK, Gorgani MK, Bandarian F, Alchondzadeh S, Sadjadi SA. Association between depression and diabetes. German J Psychiatry. 2004; 7: 62-65.

  21. Santillana-Hernández SP, Alvarado-Moctezuma LE. Depresión en población adulta mayor: tamizaje en unidad de primer nivel de atención médica. Rev Med IMSS. 1999; 37: 111-115.

  22. Colunga-Rodríguez C, García de Alba JE, Salazar-Estrada JG, Ángel-González M. Diabetes tipo 2 y depresión en Guadalajara, México. 2005. Rev Salud Pública. 2008; 10: 137-139.

  23. Zhao W, Chen Y, Lin M, Sigal RJ. Association between diabetes and depression: Sex and age differences. Public Heath. 2006; 120: 696-704.




2020     |     www.medigraphic.com